Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Clinical trial NCT04578834 · COMPLETED
Trial details
- NCT number
- NCT04578834
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-25
- Primary completion
- 2025-09-19
- Enrollment
- 518
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.